Kevin Lorenz - 01 Jan 2024 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)

Role
Director
Signature
/s/ Samuel Berry, Attorney-in-Fact
Issuer symbol
FBIO
Transactions as of
01 Jan 2024
Net transactions value
$0
Form type
4
Filing time
03 Jan 2024, 16:54:05 UTC
Previous filing
04 Jan 2023
Next filing
03 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FBIO COMMON STOCK, PAR VALUE $0.001 Award $0 +3,333 +16% $0.000000 24,304 01 Jan 2024 Direct F1, F2
holding FBIO COMMON STOCK, PAR VALUE $0.001 666 01 Jan 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split.
F2 One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service.